Correlation Between Acconeer and SenzaGen
Can any of the company-specific risk be diversified away by investing in both Acconeer and SenzaGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acconeer and SenzaGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acconeer AB and SenzaGen AB, you can compare the effects of market volatilities on Acconeer and SenzaGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acconeer with a short position of SenzaGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acconeer and SenzaGen.
Diversification Opportunities for Acconeer and SenzaGen
Modest diversification
The 3 months correlation between Acconeer and SenzaGen is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Acconeer AB and SenzaGen AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SenzaGen AB and Acconeer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acconeer AB are associated (or correlated) with SenzaGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SenzaGen AB has no effect on the direction of Acconeer i.e., Acconeer and SenzaGen go up and down completely randomly.
Pair Corralation between Acconeer and SenzaGen
Assuming the 90 days trading horizon Acconeer AB is expected to under-perform the SenzaGen. But the stock apears to be less risky and, when comparing its historical volatility, Acconeer AB is 1.53 times less risky than SenzaGen. The stock trades about -0.02 of its potential returns per unit of risk. The SenzaGen AB is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 496.00 in SenzaGen AB on April 23, 2025 and sell it today you would earn a total of 44.00 from holding SenzaGen AB or generate 8.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Acconeer AB vs. SenzaGen AB
Performance |
Timeline |
Acconeer AB |
SenzaGen AB |
Acconeer and SenzaGen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acconeer and SenzaGen
The main advantage of trading using opposite Acconeer and SenzaGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acconeer position performs unexpectedly, SenzaGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SenzaGen will offset losses from the drop in SenzaGen's long position.Acconeer vs. Cantargia AB | Acconeer vs. Fingerprint Cards AB | Acconeer vs. Smart Eye AB | Acconeer vs. Sivers IMA Holding |
SenzaGen vs. Simris Alg AB | SenzaGen vs. Immunovia publ AB | SenzaGen vs. Sedana Medical AB | SenzaGen vs. XSpray Pharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |